New publication by my PhD student on the scheduling & monitoring of gabapentin medications.
“A comprehensive analysis of jurisdiction-specific laws related to scheduling or required prescription drug monitoring of #gabapentin in the United States, 2016–2024”
www.sciencedirect.com/science/arti...
Congratulations!!
Even though my project had nothing to do with the language they are targeting, I was funded under a diversity K01 program announcement that has since been rescinded. I guess I just got caught in the middle of all of these insane actions.
My K01 was terminated last week with a revised NOA that was 4 months late from when the continuing notice should have come
Thank you 🙏🏽 It is dishertening to see so many attacks on science
Well, mine says "get s*** done" and it is often wrong 😅😅
Congrats! 🍾
Intro slide for a presentation titled “The Power of Administrative Advocacy: How Researchers Can Influence Policymaking” by Juan M. Hincapie-Castillo, PharmD, MS, PhD, President of the Board of Directors at the National Pain Advocacy Center (NPAC) and Assistant Professor of Epidemiology at the University of North Carolina at Chapel Hill. The slide includes the NPAC logo and a banner reading, “We envision a world in which pain is treated effectively, so all people living with pain can lead full and productive lives,” alongside an image of a woman. Logos for NPAC and the UNC Gillings School of Global Public Health are also present.
Speaking at the #USASP2025 Advocacy Workshop this Friday! I’ll cover how researchers can influence pain policy through rulemaking, public comments, and agency engagement.
📢Your science belongs in policy rooms too!
@usasp.bsky.social @uncpublichealth.bsky.social
#PainPolicy #Advocacy #SciComm
A classroom selfie showing a group of smiling students seated at desks with laptops and notebooks, alongside their professor in the foreground.
Wrapped up our last Intro to #LegalEpi class at @uncpublichealth.bsky.social today and feeling all kinds of grateful 🤍💙
Thanks to my students for the energy, the questions, and the hope you bring to this work. You give me faith in the future of #PublicHealth!
Picture of woman and man in professional attire standing up in front of a podium
Honored to participate as member of the planning committee and moderator for @nationalacademies.org workshop on chronic pain management and disability determinations.
Using science to advocate for people with living with pain!
#advocacy #disability #pain
Public Health Law and Ethics: Power, Duty, Restraint. 4ed by Wiley and Gostin.
Still reading though!
Exploring the Treatment and Management of Chronic Pain and Implications for Disability Determinations: A Workshop April 17 April 18
I hope you join us in the upcoming public workshop hosted by NASEM on the Treatment and Management of Chronic Pain and Implications for Disability Determinations
📅 April 17-18, 2025
🔗 Registration link: www.nationalacademies.org/event/43975_...
😱😍
Wiley Top Cited Article Congratulations to Juan Hincapie-Castillo whose work has been recognized as a top cited article in Pharmacoepidemiology and Drug Safety using joinpoint regression for drug utilization research: tutorial and case study of prescription opioid use in the united states
In a time when science faces significant challenges, celebrating even small wins becomes all the more important.
One of my papers has been recognized as one of the top 10 most cited publications in Pharmacoepidemiology and Drug Safety for 2023 🎉
onlinelibrary.wiley.com/doi/abs/10.1...
I’m sorry you couldn’t join. Happy to share slides by email.
How do legal policies shape #PainCare & #PublicHealth? Join @drjuanhc.com on Thursday for a #PittHSRseminar exploring legal epidemiology’s role in advancing equitable pain policy.
Register for Zoom or join us in person: www.gim-crhc.pitt.edu/events/hsr-s...
Gives me hope. Still waiting for my second year funding of my K01 😖
/intensesarcasm indeed 😖😖😖😫😫😫
I’ve been listening a lot of Little Girl Gone by Chinchilla
Great piece! The final assignment for the public health graduate students in my legal epidemiology class this semester is to work on a comment in response to this proposed rule.
You are right!
I am not aware of any lawsuit on 1A grounds for publications. This website is keeping track of legal challenges to action from current administration: www.justsecurity.org/107087/track...
I am not sure if pharma would like the possibility of higher liability though. Deregulation all around is their goal so let’s see how far they will push
My thinking is that reviews would not be completed in the agreed timelines despite what Congress has stipulated - staff can only do so much. I agree that other possibility could be less thorough reviews. Dangerous either way if resources are cut
And universities dead silent…
T&P for faculty like us is such a cruel joke at this point…
Right back at you! ❤️❤️❤️
